Work

Restoration of inflammatory responsiveness by metformin in endothelial cells derived from Marfan syndrome patient-specific induced pluripotent stem cells

Year: 2026
Type: article
Abstract: BACKGROUND Marfan syndrome (MFS) is a hereditary connective tissue disorder that considerably increases the risk of thoracic aortic aneurysm and dissection.Endothelial cell (EC) dysfunction is now widely regarded as a key contributor to the vascular pathology associated with MFS.AIM To characterize endothelial dysfunction in patient-specific induced pluripotent stem cellderived ECs (MFS-iECs) from patients with MFS and to determine whether metformin and resveratrol can ameliorate these abnormalities.METHODS MFS-induced pluripotent stem cells were reprogrammed from patient-derived cells and differentiated into ECs.EC proliferation, migration, angiogenesis, nitric oxide bioavailability, cellular senescence, and mitochondrial function were evaluated in MFS-iECs and wild-type iECs.Transcriptomic analysis was performed to characterize inflammatory signaling and responses to TNF-α stimulation.MFS-iECs were subsequently treated with metformin or resveratrol to assess their effects on endothelial inflammatory phenotypes.RESULTS Compared with wild-type-iECs, MFS-iECs exhibited impaired proliferation, migration, angiogenesis, and nitric oxide bioavailability, as well as accelerated cellular senescence and mitochondrial dysfunction.Transcriptomic analysis revealed hyperactivated inflammatory signaling, blunted responsiveness to TNF-α stimulation, and enhanced NF-κB pathway activity.Metformin partially restored inflammatory responsiveness to TNF-α in MFS-iECs without significantly altering basal inflammation or cellular senescence, whereas resveratrol dose-dependently suppressed basal proinflammatory cytokine expression.CONCLUSION These findings reveal profound endothelial dysfunction and inflammatory dysregulation in human MFS-iECs.Metformin and resveratrol modulate endothelial inflammation through distinct mechanisms, providing a novel translational basis for developing ECtargeted therapies in patients with MFS.
Language: English
Subfield: Genetics
Open Access status: hybrid
OpenAlex ID: W7225997807
FWCI:
Cites: 48
Cited by:
Related to: 10